Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
about
Anti-tumor activity of metformin: from metabolic and epigenetic perspectivesChemotherapy regimen based on sorafenib combined with 5-FU on HIF-1α and VEGF expression and survival in advanced gastric cancer patients.Intermittent calorie restriction enhances epithelial-mesenchymal transition through the alteration of energy metabolism in a mouse tumor model.Comparison of specific expression profile in two in vitro hypoxia models.The Oncojanus Paradigm of Respiratory Complex I.
P2860
Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Metformin increases PDH and su ...... oral squamous cell carcinoma.
@en
Metformin increases PDH and su ...... oral squamous cell carcinoma.
@nl
type
label
Metformin increases PDH and su ...... oral squamous cell carcinoma.
@en
Metformin increases PDH and su ...... oral squamous cell carcinoma.
@nl
prefLabel
Metformin increases PDH and su ...... oral squamous cell carcinoma.
@en
Metformin increases PDH and su ...... oral squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Metformin increases PDH and su ...... oral squamous cell carcinoma.
@en
P2093
Alfredo Maurício Batista de Paula
Carlos Alberto de Carvalho Fraga
Eliane Sobrinho Santos
John David Feltenberger
Leandro de Freitas Teles
Lissur Azevedo Orsini
Lucyana Conceição Farias
Marcela Gonçalves de Souza
Sabrin Ferreira de Jesus
Sérgio Henrique Sousa Santos
P2860
P304
55057-55068
P356
10.18632/ONCOTARGET.10842
P407
P577
2016-07-26T00:00:00Z